Table 2 Clinical and neutralization information from BNT162b2 vaccinated individuals.
ID | COVID-19 diagnosis | Gender | First dose | Boost | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
Day post vaccine at the time of sampling post first vaccine dose | ID50 | R2 | Neutralization at 1:20 dilution | Day post vaccine at the time of sampling post second vaccine dose | ID50 | R2 | Neutralization at 1:20 dilution | |||
39 | Negative | F | 16 | 0.001683 | 0.992 | 90.14 | 28 | 0.000554 | 0.986 | 96.9301 |
40 | Negative | F | 14 | 0.00226 | 0.999 | 92.78 | 29 | 0.002394 | 1.000 | 96.44067 |
41 | Negative | F | 14 | 0.005097 | 0.990 | 88.19 | 29 | 0.003490 | 0.996 | 84.58632 |
42 | Positive recovered | M | 14 | 0.001225 | 0.996 | 89.29 | 28 | 0.000724 | 0.999 | 96.60476 |
43 | Negative | M | 14 | 0.005883 | 0.988 | 92.08 | 29 | 0.000278 | 1.000 | 97.20769 |
44 | Negative | F | 16 | 0.004726 | 0.989 | 67.14 | 28 | 0.003606 | 1.000 | 90.51702 |
45 | Negative | M | 16 | 0.002407 | 0.995 | 93.80 | 28 | 0.001136 | 0.992 | 97.01511 |
46 | Negative | F | 16 | 0.001298 | 0.994 | 93.57 | 27 | 0.000439 | 0.999 | 96.9073 |
47 | Positive recovered | M | 16 | 0.000781 | 0.951 | 93.25 | 27 | 0.000683 | 0.993 | 95.5364521 |
48 | Negative | F | 16 | 0.000916 | 0.979 | 98.04 | 27 | 0.000940 | 1.000 | 97.5876662 |
49 | Negative | F | 14 | 0.001746 | 0.995 | 97.60 | 28 | 0.001864 | 0.992 | 97.5088973 |
50 | Negative | F | 14 | 0.001030 | 0.986 | 97.36 | 28 | 0.001096 | 0.999 | 98.0660083 |
51 | Positive recovered | F | 14 | 0.003675 | 0.980 | 92.60 | 28 | 0.001998 | 0.997 | 97.1587337 |
52 | Positive recovered | F | 13 | 0.001203 | 0.998 | 96.58 | 27 | 0.004783 | 0.997 | 78.7588167 |
53 | Positive recovered | F | 16 | 0.000000 | 0.998 | 91.51 | NA | 0.000967 | 0.975 | 97.5596675 |
54 | Positive recovered | F | 16 | 0.003309 | 0.981 | 89.43 | 28 | 0.001489 | 0.981 | 95.2267471 |
